168 related articles for article (PubMed ID: 17319292)
1. Two new vaccines: Gardasil and Rotateq.
Van Gilder D
S D Med; 2007 Jan; 60(1):13-4. PubMed ID: 17319292
[No Abstract] [Full Text] [Related]
2. For cancers caused by HPV, two vaccines were just the beginning.
Peres J
J Natl Cancer Inst; 2011 Mar; 103(5):360-2. PubMed ID: 21357595
[No Abstract] [Full Text] [Related]
3. FDA approves new upgraded Gardasil 9.
Kirby T
Lancet Oncol; 2015 Feb; 16(2):e56. PubMed ID: 25532625
[No Abstract] [Full Text] [Related]
4. Assessing the HPV vaccine: researchers confront complex interplay of factors.
Tuma RS
J Natl Cancer Inst; 2009 Apr; 101(7):444-5. PubMed ID: 19318636
[No Abstract] [Full Text] [Related]
5. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
[TBL] [Abstract][Full Text] [Related]
6. Who should get the HPV vaccine?
Pichichero ME
J Fam Pract; 2007 Mar; 56(3):197-202. PubMed ID: 17343808
[No Abstract] [Full Text] [Related]
7. RotaTeq: a new oral rotavirus vaccine.
Med Lett Drugs Ther; 2006 Jul; 48(1240):61-3. PubMed ID: 16874281
[No Abstract] [Full Text] [Related]
8. Human papillomavirus vaccination: expected impacts and unresolved issues.
Dempsey AF; Freed GL
J Pediatr; 2008 Mar; 152(3):305-9. PubMed ID: 18280831
[No Abstract] [Full Text] [Related]
9. RotaTeq for prevention of rotavirus gastroenteritis.
Laustsen G
Nurse Pract; 2006 Aug; 31(8):54-5. PubMed ID: 16966977
[No Abstract] [Full Text] [Related]
10. Human papillomavirus, vaccines and women's health: questions and cautions.
Lippman A; Melnychuk R; Shimmin C; Boscoe M
CMAJ; 2007 Aug; 177(5):484-7. PubMed ID: 17671239
[No Abstract] [Full Text] [Related]
11. Human papillomavirus vaccine: waiting for a miracle.
MacDonald N; Hébert PC
CMAJ; 2007 Aug; 177(5):433, 435. PubMed ID: 17724313
[No Abstract] [Full Text] [Related]
12. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
[TBL] [Abstract][Full Text] [Related]
13. Cervarix--a second HPV vaccine.
Med Lett Drugs Ther; 2010 May; 52(1338):37-8. PubMed ID: 20467355
[No Abstract] [Full Text] [Related]
14. Primary and secondary prevention of cervical cancer--opportunities and challenges.
Markowitz LE; Unger ER; Saraiya M
J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
[No Abstract] [Full Text] [Related]
15. Immunization update: latest recommendations from the CDC.
Campos-Outcalt D
J Fam Pract; 2007 May; 56(5):377-80. PubMed ID: 17475169
[No Abstract] [Full Text] [Related]
16. The HPV vaccine: a major public health breakthrough.
Gerbert D;
JAAPA; 2007 Mar; 20(3):17-8. PubMed ID: 17416019
[No Abstract] [Full Text] [Related]
17. From human papillomavirus to cervical cancer.
Hang Lee S
Obstet Gynecol; 2010 Nov; 116(5):1221; author reply 221-2. PubMed ID: 20966723
[No Abstract] [Full Text] [Related]
18. Reducing patient risk for human papillomavirus infection and cervical cancer.
Herbert J; Coffin J
J Am Osteopath Assoc; 2008 Feb; 108(2):65-70. PubMed ID: 18303060
[TBL] [Abstract][Full Text] [Related]
19. [Papillomavirus vaccines now allowed--ethical and logistical considerations].
Höpfl R
J Dtsch Dermatol Ges; 2007 May; 5(5):349-52. PubMed ID: 17451379
[No Abstract] [Full Text] [Related]
20. Rationale and implementation policy for use of oral, live, reassortant rotavirus vaccine in the neonatal intensive care unit.
Shah SI
Adv Neonatal Care; 2008 Jun; 8(3):148-9. PubMed ID: 18535419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
